• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[皮肤淋巴增殖性疾病和卡波西肉瘤患者的干扰素状态]

[The interferon status of patients with lymphoproliferative diseases of the skin and Kaposi's sarcoma].

作者信息

Faradzhev Z G, Samsonov V A, Parfenova T M, Malinovskaia V V

出版信息

Vestn Dermatol Venerol. 1990(7):4-7.

PMID:1701592
Abstract

Differences in the interferon status of various nature were revealed in patients with lymphoproliferative diseases of the skin and with Kaposi's sarcoma, whose interferon system was examined in respect of its three major parameters. Such data are a sufficient basis for the correction of the detected changes by interferon preparations combined with other chemical drugs. Two parameters of the interferon system may serve as criteria of interferon therapy efficacy: increased alpha-interferon level and, more so, normalization of the gamma component of interferon production, tested by the gamma parameter.

摘要

在对皮肤淋巴增殖性疾病患者和卡波西肉瘤患者的干扰素系统的三个主要参数进行检查时,发现了不同性质的干扰素状态差异。这些数据足以作为通过干扰素制剂与其他化学药物联合来纠正检测到的变化的依据。干扰素系统的两个参数可作为干扰素治疗效果的标准:α干扰素水平升高,更重要的是,通过γ参数检测的干扰素产生的γ成分正常化。

相似文献

1
[The interferon status of patients with lymphoproliferative diseases of the skin and Kaposi's sarcoma].[皮肤淋巴增殖性疾病和卡波西肉瘤患者的干扰素状态]
Vestn Dermatol Venerol. 1990(7):4-7.
2
[The immune status of patients with lymphoproliferative diseases of the skin and Kaposi's sarcoma].
Vestn Dermatol Venerol. 1990(1):16-20.
3
[Disordered cell-receptor metabolism (R-proteins) and the immunity indices in patients with lymphoproliferative diseases of the skin and Kaposi's sarcoma].
Vestn Dermatol Venerol. 1990(10):17-20.
4
Human herpesvirus 8 infection in patients with cutaneous lymphoproliferative diseases.皮肤淋巴增殖性疾病患者中的人疱疹病毒8感染
Arch Dermatol. 2005 Oct;141(10):1235-42. doi: 10.1001/archderm.141.10.1235.
5
[The effect of therapy on the immunological indices in patients with skin lymphomas and Kaposi's sarcoma].[治疗对皮肤淋巴瘤和卡波西肉瘤患者免疫指标的影响]
Vestn Dermatol Venerol. 1990(5):26-30.
6
[Behavior of serum fibrinogen in neoplasms and cutaneous reticulosis].[血清纤维蛋白原在肿瘤及皮肤网状细胞增多症中的表现]
G Ital Dermatol Minerva Dermatol. 1966 Sep-Dec;107(5):413-20.
7
Interferon and interferon inactivators in patients with acquired immune deficiency syndrome and Kaposi's sarcoma. A preliminary report.获得性免疫缺陷综合征和卡波西肉瘤患者体内的干扰素及干扰素灭活剂。初步报告。
Res Commun Chem Pathol Pharmacol. 1984 Aug;45(2):271-7.
8
[The cytotoxic effect of the thrombocytes from patients with mycosis fungoides and Kaposi's sarcoma].
Vestn Dermatol Venerol. 1990(11):34-6.
9
Monitoring of endogenous interferon-alpha and human herpesvirus 8 in HIV-infected patients with Kaposi's sarcoma.对感染人类免疫缺陷病毒且患有卡波西肉瘤的患者体内内源性α干扰素和人类疱疹病毒8的监测。
Eur J Med Res. 2002 Jan 29;7(1):19-24.
10
[The effectiveness of treating patients with malignant skin lymphoma and Kaposi's sarcoma studied via polyamines].[通过多胺研究治疗恶性皮肤淋巴瘤和卡波西肉瘤患者的疗效]
Vestn Dermatol Venerol. 1989(11):20-5.